1. Home
  2. Labeler Index
  3. L.n.k. International, Inc.
  4. 50844-263
  5. NDC Package Code: 50844-263-44 Nasal Decongestant

NDC Package 50844-263-44 Nasal Decongestant

Phenylephrine Hcl Tablet, Film Coated Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
50844-263-44
Package Description:
1 BLISTER PACK in 1 CARTON / 18 TABLET, FILM COATED in 1 BLISTER PACK
Product Code:
50844-263
Proprietary Name:
Nasal Decongestant
Non-Proprietary Name:
Phenylephrine Hcl
Substance Name:
Phenylephrine Hydrochloride
Usage Information:
This medication is used for temporary relief of congestion in the nose caused by various conditions including the common cold, sinusitis, hay fever, and allergies. It works by narrowing the blood vessels in the nose area, reducing swelling and congestion.
11-Digit NDC Billing Format:
50844026344
NDC to RxNorm Crosswalk:
  • RxCUI: 1049182 - phenylephrine HCl 10 MG Oral Tablet
  • RxCUI: 1049182 - phenylephrine hydrochloride 10 MG Oral Tablet
    • Product Type:
    Human Otc Drug
    Labeler Name:
    L.n.k. International, Inc.
    Dosage Form:
    Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • PHENYLEPHRINE HYDROCHLORIDE 10 mg/1
    • Pharmacologic Class(es):
  • Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
  • alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    part341
    Marketing Category:
    OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
    Start Marketing Date:
    08-05-2019
    End Marketing Date:
    06-16-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 50844-263-44?

    The NDC Packaged Code 50844-263-44 is assigned to a package of 1 blister pack in 1 carton / 18 tablet, film coated in 1 blister pack of Nasal Decongestant, a human over the counter drug labeled by L.n.k. International, Inc.. The product's dosage form is tablet, film coated and is administered via oral form.

    Is NDC 50844-263 included in the NDC Directory?

    Yes, Nasal Decongestant with product code 50844-263 is active and included in the NDC Directory. The product was first marketed by L.n.k. International, Inc. on August 05, 2019.

    What is the 11-digit format for NDC 50844-263-44?

    The 11-digit format is 50844026344. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-250844-263-445-4-250844-0263-44